JCI - Citations to Increased C5a receptor expression in sepsis

Citations to this article

Increased C5a receptor expression in sepsis

Niels C. Riedemann, … , Firas S. Zetoune, Peter A. Ward

Niels C. Riedemann, … , Firas S. Zetoune, Peter A. Ward

Published July 1, 2002
Citation Information: J Clin Invest. 2002;110(1):101-108. https://doi.org/10.1172/JCI15409.

View: Text | PDF

Article Immunology

Total citations by year

Year:	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002	Total
Citations:	3	3	2	2	5	3	3	3	3	2	2	1	4	10	4	5	6	2	4	5	5	2	2	81

Citation information

Citations to this article (81)

Title and authors	Publication	Year
Identification of a genetic region linked to tolerance to MRSA infection using Collaborative Cross mice. Nagarajan A, Scoggin K, Adams LG, Threadgill D, Andrews-Polymenis H	PLoS genetics	2024
Pathophysiological dynamics in the contact, coagulation, and complement systems during sepsis: Potential targets for nafamostat mesilate He Q, Wei Y, Qian Y, Zhong M	Journal of Intensive Medicine	2024
Africanized honeybee venom (Apis mellifera) promotes human complement activation split products storm Silva de França F, de Oliveira Orsi R, Fernandes DC, Leonel TB, Tambourgi DV	Frontiers in Immunology	2024
FBXO11 governs macrophage cell death and inflammation in response to bacterial toxins Jeon Y, Chow SH, Stuart I, Weir A, Yeung AT, Hale C, Sridhar S, Dougan G, Vince JE, Naderer T	Life science alliance	2023
Complement as a vital nexus of the pathobiological connectome for acute respiratory distress syndrome: An emerging therapeutic target Yang Z, Nicholson SE, Cancio TS, Cancio LC, Li Y	Frontiers in immunology	2023
Inflammatory mechanisms and intervention strategies for sepsis‐induced myocardial dysfunction Nong Y, Wei X, Yu D	Immunity, Inflammation and Disease	2023
3'mRNA sequencing reveals pro-regenerative properties of c5ar1 during resolution of murine acetaminophen-induced liver injury. Gonther S, Bachmann M, Goren I, Huard A, Weigert A, Köhl J, Mühl H	npj Regenerative Medicine	2022
The Immunopathogenesis of Polymicrobial Sepsis Zetoune FS, Ward PA	Shock (Augusta, Ga.)	2022
Role of the C5a-C5a receptor axis in the inflammatory responses of the lungs after experimental polytrauma and hemorrhagic shock S Chakraborty, VE Winkelmann, S Braumüller, A Palmer, A Schultze, B Klohs, A Ignatius, A Vater, M Fauler, M Frick, M Huber-Lang	Scientific Reports	2021
Complement Regulation in Human Tenocytes under the Influence of Anaphylatoxin C5a S Silawal, B Kohl, J Shi, G Schulze-Tanzil	International journal of molecular sciences	2021
Sepsis therapies: learning from 30 years of failure of translational research to propose new leads JM Cavaillon, M Singer, T Skirecki	EMBO Molecular Medicine	2020
Association of COVID-19 inflammation with activation of the C5a–C5aR1 axis J Carvelli, O Demaria, F Vély, L Batista, NC Benmansour, J Fares, S Carpentier, ML Thibult, A Morel, R Remark, P André, A Represa, C Piperoglou, PY Cordier, EL Dault, C Guervilly, P Simeone, M Gainnier, Y Morel, M Ebbo, N Schleinitz, E Vivier	Nature	2020
Targeting Complement C5a Receptor 1 for the Treatment of Immunosuppression in Sepsis O Sommerfeld, A Medyukhina, S Neugebauer, M Ghait, S Ulferts, A Lupp, R König, R Wetzker, S Schulz, MT Figge, M Bauer, AT Press	Molecular Therapy	2020
Pre-existing antibody-mediated adverse effects prevent the clinical development of a bacterial anti-inflammatory protein AT Tromp, Y Zhao, I Jongerius, EC Heezius, P Abrial, M Ruyken, JA van Strijp, CJ de Haas, AN Spaan, KP van Kessel, T Henry, PJ Haas	Disease models & mechanisms	2020
Role of Complement and Histones in Sepsis FS Zetoune, PA Ward	Frontiers in Medicine	2020
Targeting Complement Pathways in Polytrauma- and Sepsis-Induced Multiple-Organ Dysfunction E Karasu, B Nilsson, J Köhl, JD Lambris, M Huber-Lang	Frontiers in immunology	2019
Distinct roles of the anaphylatoxin receptors C3aR, C5aR1 and C5aR2 in experimental meningococcal infections M Muenstermann, L Strobel, A Klos, RA Wetsel, TM Woodruff, J Köhl, KO Johswich	Virulence	2019
High Concentration of C5a-Induced Mitochondria-Dependent Apoptosis in Murine Kidney Endothelial Cells IJ Tsai, WC Lin, YH Yang, YL Tseng, YH Lin, CH Chou, YK Tsau	International journal of molecular sciences	2019
Role of complement C5a and histones in septic cardiomyopathy F Fattahi, LM Frydrych, G Bian, M Kalbitz, TJ Herron, EA Malan, MJ Delano, PA Ward	Molecular Immunology	2018
Myocardial expression of the anaphylatoxin receptor C3aR is associated with cardiac inflammation and prognosis in patients with non-ischaemic heart failure: Anaphylatoxin receptors in non-ischaemic heart failure KA Mueller, J Patzelt, M Sauter, P Maier, S Gekeler, K Klingel, R Kandolf, P Seizer, M Gawaz, T Geisler, HF Langer	ESC Heart Failure	2018
Complement C5a Receptor 1 Exacerbates the Pathophysiology of N. meningitidis Sepsis and Is a Potential Target for Disease Treatment JB Herrmann, M Muenstermann, L Strobel, A Schubert-Unkmeir, TM Woodruff, SD Gray-Owen, A Klos, KO Johswich, R Rappuoli	mBio	2018
Fc microparticles can modulate the physical extent and magnitude of complement activity BA Holt, MC Bellavia, D Potter, D White, SR Stowell, T Sulchek	Biomaterials Science	2017
Neuroprotective effects of intravenous immunoglobulin are mediated through inhibition of complement activation and apoptosis in a rat model of sepsis F Esen, G Orhun, PE Ozcan, E Senturk, M Kucukerden, M Giris, U Akcan, CU Yilmaz, N Orhan, N Arican, M Kaya, SB Gazioglu, E Tuzun	Intensive Care Medicine Experimental	2017
Glycogen synthase kinase-3β inhibitor reduces LPS-induced acute lung injury in mice Q Ding, G Liu, Y Zeng, J Zhu, Z Liu, J Jiang, J Huang	Molecular medicine reports	2017
Immunomodulatory and Antimicrobial Activity of Babassu Mesocarp Improves the Survival in Lethal Sepsis ES Barroqueiro, DS Prado, PS Barcellos, TA Silva, WS Pereira, LA Silva, MC Maciel, RB Barroqueiro, FR Nascimento, AG Gonçalves, RN Guerra	Evidence-Based Complementary and Alternative Medicine	2016
Role of Complement C5 in Experimental Blunt Chest Trauma-Induced Septic Acute Lung Injury (ALI) M Kalbitz, M Karbach, S Braumueller, P Kellermann, F Gebhard, M Huber-Lang, M Perl, B Ryffel	PloS one	2016
Alternative Pathway Inhibition by Exogenous Factor H Fails to Attenuate Inflammation and Vascular Leakage in Experimental Pneumococcal Sepsis in Mice E der Maten, S Selm, JD Langereis, HJ Bootsma, FJ van Opzeeland, R Groot, MI de Jonge, M der Flier, CM Stover	PloS one	2016
On the Functional Overlap between Complement and Anti-Microbial Peptides J Zimmer, J Hobkirk, F Mohamed, MJ Browning, CM Stover	Frontiers in immunology	2015
Properdin Levels in Human Sepsis CM Stover, J McDonald, S Byrne, DG Lambert, JP Thompson	Frontiers in immunology	2015
Complement mediates a primed inflammatory response after traumatic lung injury: JJ Hoth, JD Wells, SE Jones, BK Yoza, CE McCall	Journal of Trauma and Acute Care Surgery	2014
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) prevents lipopolysaccharide (LPS)-induced, sepsis-related severe acute lung injury in mice Y Takaoka, S Goto, T Nakano, HP Tseng, SM Yang, S Kawamoto, K Ono, CL Chen	Scientific Reports	2014
Complement in animal development: Unexpected roles of a highly conserved pathway JD Leslie, R Mayor	Seminars in Immunology	2013
Sphingosine Kinase 1 Mediation of Expression of the Anaphylatoxin Receptor C5L2 Dampens the Inflammatory Response to Endotoxin K Bachmaier, E Guzman, T Kawamura, X Gao, AB Malik	PloS one	2012
Neutrophils orchestrate their own recruitment in murine arthritis through C5aR and FcγR signaling CD Sadik, ND Kim, Y Iwakura, AD Luster	Proceedings of the National Academy of Sciences	2012
Manipulation of the Complement System for Benefit in Sepsis PA Ward, RF Guo, NC Riedemann	Critical care research and practice	2012
New insights for C5a and C5a receptors in sepsis C Yan, H Gao	Frontiers in immunology	2012
Beneficial and Detrimental Effects of Plasmin(ogen) during Infection and Sepsis in Mice Y Guo, J Li, E Hagström, T Ny	PloS one	2011
The Membrane Attack Complex of Complement is Required for the Development of Murine Experimental Cerebral Malaria TN Ramos, MM Darley, X Hu, O Billker, JC Rayner, M Ahras, JE Wohler, SR Barnum	Journal of immunology (Baltimore, Md. : 1950)	2011
γδT-cell function in sepsis is modulated by C5a receptor signalling G Han, S Geng, Y Li, G Chen, R Wang, X Li, Y Ma, B Shen, Y Li	Immunology	2011
Molecular mechanisms of inflammation and tissue injury after major trauma-is complement the "bad guy"? MD Neher, S Weckbach, MA Flierl, MS Huber-Lang, PF Stahel	Journal of Biomedical Science	2011
Systemic mast cell degranulation increases mortality during polymicrobial septic peritonitis in mice EJ Seeley, RE Sutherland, SS Kim, PJ Wolters	Journal of leukocyte biology	2011
Is CaMKII a link between inflammation and hypertrophy in heart? MV Singh, ME Anderson	Journal of Molecular Medicine	2011
MHC class I–specific antibody binding to nonhematopoietic cells drives complement activation to induce transfusion-related acute lung injury in mice RT Strait, W Hicks, N Barasa, A Mahler, M Khodoun, J Köhl, K Stringer, D Witte, NV Rooijen, BM Susskind, FD Finkelman	Journal of Experimental Medicine	2011
Distinct different contributions of the alternative and classical complement activation pathway for the innate host response during sepsis K Dahlke, CD Wrann, O Sommerfeld, M Sossdorf, P Recknagel, S Sachse, SW Winter, A Klos, GL Stahl, YX Ma, RA Claus, K Reinhart, M Bauer, NC Riedemann	Journal of immunology (Baltimore, Md. : 1950)	2011
Genetic analysis of C5a receptors in neutrophils from patients with familial Mediterranean fever E Apostolidou, K Kambas, A Chrysanthopoulou, I Kourtzelis, M Speletas, K Ritis, I Mitroulis	Molecular Biology Reports	2011
MyD88-dependent production of IL-17F is modulated by the anaphylatoxin C5a via the Akt signaling pathway M Bosmann, VR Patel, NF Russkamp, F Pache, FS Zetoune, JV Sarma, PA Ward	The FASEB Journal	2011
Complement activation in emergency department patients with severe sepsis JG Younger, DO Bracho, HM Chung-Esaki, M Lee, GK Rana, A Sen, AE Jones	Academic Emergency Medicine	2010
C5a promotes migration, proliferation, and vessel formation in endothelial cells R Kurihara, K Yamaoka, N Sawamukai, S Shimajiri, K Oshita, S Yukawa, M Tokunaga, S Iwata, K Saito, K Chiba, Y Tanaka	Inflammation Research	2010
Role of C5 Activation Products in Sepsis PA Ward	TheScientificWorldJournal	2010
C5a receptor enables participation of mast cells in immune complex arthritis independent of Fc γ receptor modulation PA Nigrovic, O Malbec, B Lu, MM Markiewski, C Kepley, N Gerard, C Gerard, M Daëron, DM Lee	Arthritis & Rheumatism	2010
Pulmonary surfactant: an immunological perspective ZC Chroneos, Z Sever-Chroneos, VL Shepherd	Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology	2009
ELIMINATION OF C5AR PREVENTS INTESTINAL MUCOSAL DAMAGE AND ATTENUATES NEUTROPHIL INFILTRATION IN LOCAL AND REMOTE ORGANS DZ Xu, SB Zaets, R Chen, Q Lu, H Rajan, X Yang, J Zhang, E Feketova, N Bogdan, EA Deitch, Y Cao	Shock	2009
Inhibition of complement C5a prevents breakdown of the blood-brain barrier and pituitary dysfunction in experimental sepsis MA Flierl, PF Stahel, D Rittirsch, M Huber-Lang, AD Niederbichler, LM Hoesel, BM Touban, SJ Morgan, WR Smith, PA Ward, K Ipaktchi	Critical Care	2009
Activation by C5a of endothelial cell caspase 8 and cFLIP EA Albrecht, JV Sarma, PA Ward	Inflammation research : official journal of the European Histamine Research Society ... [et al.]	2009
Attenuation of IgG immune complex-induced acute lung injury by silencing C5aR in lung epithelial cells L Sun, RF Guo, H Gao, JV Sarma, FS Zetoune, PA Ward	The FASEB Journal	2009
Sepsis, apoptosis and complement PA Ward	Biochemical Pharmacology	2008
Therapeutic potential of HMGB1-targeting agents in sepsis H Wang, S Zhu, R Zhou, W Li, AE Sama	Expert Reviews in Molecular Medicine	2008
Complement component C5a mediates hemorrhage-induced intestinal damage SD Fleming, LM Phillips, JD Lambris, GC Tsokos	The Journal of surgical research	2008
C5 deficiency and C5a or C5aR blockade protects against cerebral malaria SN Patel, J Berghout, FE Lovegrove, K Ayi, A Conroy, L Serghides, G Min-oo, DC Gowda, JV Sarma, D Rittirsch, PA Ward, WC Liles, P Gros, KC Kain	Journal of Experimental Medicine	2008
Disruption of the C5a receptor gene increases resistance to acute Gram-negative bacteremia and endotoxic shock: Opposing roles of C3a and C5a TJ Hollmann, SL Mueller-Ortiz, MC Braun, RA Wetsel	Molecular Immunology	2008
Anticomplement therapy. Kulkarni PA, Afshar-Kharghan V	Biologics : targets & therapy	2008
THE PRIMING EFFECT OF C5A ON MONOCYTES IS PREDOMINANTLY MEDIATED BY THE P38 MAPK PATHWAY: V Schaeffer, J Cuschieri, I Garcia, M Knoll, J Billgren, S Jelacic, E Bulger, R Maier	Shock	2007
The N-formyl peptide receptors and the anaphylatoxin C5a receptors: An overview M Rabiet, E Huet, F Boulay	Biochimie	2007
Nrf2 is a critical regulator of innate immune response and survival during experimental sepsis Rajesh K. Thimmulappa, Hannah Lee, Tirumalai Rangasamy, Shekar P Reddy, Thomas W. Kensler, Masayuki Yamamoto and Shyam Biswal	Journal of Clinical Investigation	2006
Thrombin-activatable procarboxypeptidase B regulates activated complement C5a in vivo T Nishimura, T Myles, AM Piliposky, PN Kao, GJ Berry, LL Leung	Blood	2006
Adenovirus-Mediated In Vivo Silencing of Anaphylatoxin Receptor C5aR L Sun, H Gao, VJ Sarma, R Guo, PA Ward	Journal of Biomedicine and Biotechnology	2006
New Insights into Cellular Mechanisms During Sepsis LM Hoesel, H Gao, PA Ward	Immunologic Research	2006
Role of C5 in the Development of Airway Inflammation, Airway Hyperresponsiveness and On-going Airway Response Tao Peng, Liming Hao, Joseph Madri, Xiao Su, Jack A. Elias, Gregory Stahl, Stephen Squinto and Yi Wang	Journal of Clinical Investigation	2005
An essential role for complement C5a in the pathogenesis of septic cardiac dysfunction AD Niederbichler, LM Hoesel, MV Westfall, H Gao, KR Ipaktchi, L Sun, FS Zetoune, GL Su, S Arbabi, JV Sarma, SC Wang, MR Hemmila, PA Ward	Journal of Experimental Medicine	2005
Complement C5 and Early Oxygen Kinetics during Murine Sepsis G Valencia	Academic Emergency Medicine	2005
Acute lung injury and the acute respiratory distress syndrome: four decades of inquiry into pathogenesis and rational management MA Matthay, GA Zimmerman	American journal of respiratory cell and molecular biology	2005
Complement-induced impairment of the innate immune system during sepsis EA Albrecht, PA Ward	Current Infectious Disease Reports	2005
Current and Future Concepts of Abdominal Sepsis K Emmanuel, H Weighardt, H Bartels, JR Siewert, B Holzmann	World Journal of Surgery	2004
Complement-induced impairment of the innate immune system during sepsis EA Albrecht, PA Ward	Current Allergy and Asthma Reports	2004
Bedeutung der angeborenen Immunantwort in der Sepsis C Hörner, A Bouchon, A Bierhaus, PP Nawroth, E Martin, HJ Bardenheuer, MA Weigand	Der Anaesthesist	2004
C5a-induced gene expression in human umbilical vein endothelial cells. Albrecht EA, Chinnaiyan AM, Varambally S, Kumar-Sinha C, Barrette TR, Sarma JV, Ward PA	The American Journal of Pathology	2004
Disturbed homeostasis of lung intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 during sepsis. Laudes IJ, Guo RF, Riedemann NC, Speyer C, Craig R, Sarma JV, Ward PA	The American Journal of Pathology	2004
The enigma of sepsis NC Riedemann, RF Guo, PA Ward	Journal of Clinical Investigation	2003
Expression of vascular adhesion protein-1 in normal and inflamed mice lungs and normal human lungs B Singh, T Tschernig, M van Griensven, A Fieguth, R Pabst	Virchows Archiv	2003
C5a anaphylatoxin is a major regulator of activating versus inhibitory FcgRs in immune complex induced lung disease Nelli Shushakova, Julia Skokowa, Jurriaan Schulman, Ulrich Baumann, Jörg Zwirner, Reinhold E. Schmidt, and J. Engelbert Gessner	Journal of Clinical Investigation	2002
C5a anaphylatoxin is a major regulator of activating versus inhibitory FcγRs in immune complex–induced lung disease Shushakova N, Skokowa J, Schulman J, Baumann U, Zwirner J, Schmidt RE, Gessner JE	Journal of Clinical Investigation	2002

Advertisement